In March of this year, the FDA gave their approval to Spravato, which is a nasal spray that contains esketamine, which is itself derived from the anesthetic ketamine. Spravato has been approved as a prescription-only drug given – along with another form of anti-depressant – to people who are proving … [Read more...] about What Makes Using Ketamine for Depression So Different Compared to Other Options?